EDITORIALS

Beyond the Development of Quality-of-Life Instruments: Where Do We Go From Here?

Mark N. Levine and Patricia A. Ganz

JCO May 1 2002: 2215–2216. [Full Text] [PDF]

Targeting the Epidermal Growth Factor Receptor With Tyrosine Kinase Inhibitors: Small Molecules, Big Hopes

Jose Baselga

JCO May 1 2002: 2217–2219. [Full Text] [PDF]

Shedding Old Paradigms: Developing Viruses to Treat Cancer

Emily K. Bergsland and Alan P. Venook

JCO May 1 2002: 2220–2222. [Full Text] [PDF]

Low-Grade Gliomas: Answering One Question in a Myriad of New Questions

John M. Buatti, Sanford L. Meeks, Timothy C. Ryken, and Thomas L. Carlisle

JCO May 1 2002: 2223–2224. [Full Text] [PDF]

Reducing Treatment-Related Morbidity and Mortality in Early-Stage Hodgkin’s Disease and Why the Recent Southwest Oncology Group Trial Is Not the Way to Go

Leonard R. Prosnitz

JCO May 1 2002: 2225–2228. [Full Text] [PDF]

SUPPORTIVE CARE AND QUALITY OF LIFE
	Measuring Health-Related Quality of Life in Patients With Hepatobiliary Cancers: The Functional Assessment of Cancer Therapy–Hepatobiliary Questionnaire
	Nancy Heffernan, David Cella, Kimberly Webster, Linda Odom, Mary Martone, Steven Passik, Marilyn Bookbinder, Yuman Fong, William Jarnagin, and Leslie Blumgart
	JCO May 1 2002: 2229–2239. [Abstract] [Full Text] [PDF]

PHASE I AND CLINICAL PHARMACOLOGY
	ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Trial
	Malcolm Ranson, Lisa A. Hammond, David Ferry, Mark Kris, Andrew Tullo, Philip I. Murray, Vince Miller, Steve Averbuch, Judy Ochs, Charles Morris, Andrea Feyereislova, Helen Swaisland, and Eric K. Rowinsky
	JCO May 1 2002: 2240–2250. [Abstract] [Full Text] [PDF]
	Phase I Trial of Intravenous Administration of PV701, an Oncolytic Virus, in Patients With Advanced Solid Cancers
	Andrew L. Pecora, Naiyer Rizvi, Gary I. Cohen, Neal J. Meropol, Daniel Sterman, John L. Marshall, Stuart Goldberg, Peter Gross, James D. O’Neil, William S. Groene, M. Scot Roberts, Harvey Rabin, Michael K. Bamat, and Robert M. Lorence
	JCO May 1 2002: 2251–2266. [Abstract] [Full Text] [PDF]

CENTRAL NERVOUS SYSTEM
	Prospective Randomized Trial of Low- Versus High-Dose Radiation Therapy in Adults With Supratentorial Low-Grade Glioma: Initial Report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group Study
	E. Shaw, R. Arusell, B. Scheithauer, J. O’Fallon, B. O’Neill, R. Dinapoli, D. Nelson, J. Earle, C. Jones, T. Cascino, D. Nichols, R. Ivnik, R. Hellman, W. Curran, and R. Abrams
	JCO May 1 2002: 2267–2276. [Abstract] [Full Text] [PDF]
	Phase II Trial of Carmustine Plus O6-Benzylguanine for Patients With Nitrosourea-Resistant Recurrent or Progressive Malignant Glioma
	Jennifer A. Quinn, James Pluda, M. Eileen Dolan, Shannon Delaney, Richard Kaplan, Jeremy N. Rich, Allan H. Friedman, David A. Reardon, John H. Sampson, O. Michael Colvin, Michael M. Haglund, Anthony E. Pegg, Robert C. Moschel, Roger E. McLendon, James M. Provenzale, Sridharan Gururangan, Sandra Tourt-Uhlig, James E. Herndon, II, Darell D. Bigner, and Henry S. Friedman
	JCO May 1 2002: 2277–2283. [Abstract] [Full Text] [PDF]

ORIGINAL REPORTS
Pediatric Oncology
	Treatment of High-Risk Neuroblastoma With Triple-Tandem High-Dose Therapy and Stem-Cell Rescue: Results of the Chicago Pilot II Study
	Morris Kletzel, Howard M. Katzenstein, Paul R. Haut, Alice L. Yu, Elaine Morgan, Marleta Reynolds, Grant Geissler, Maryanne H. Marymount, Dachao Liu, John A. Kalapurakal, Richard M. Shore, Diana M.E. Bardo, Jennifer Schmoldt, Alfred W. Rademaker, and Susan L. Cohn
	JCO May 1 2002: 2284–2292. [Abstract] [Full Text] [PDF]
	Non-Hodgkin’s Lymphoma Arising in Bone in Children and Adolescents Is Associated With an Excellent Outcome: A Children’s Cancer Group Report
	Mark A. Lones, Sherrie L. Perkins, Richard Sposto, Nicole Tedeschi, Marshall E. Kadin, Carl R. Kjeldsberg, John F. Wilson, David L. Zwick, and Mitchell S. Cairo
	JCO May 1 2002: 2293–2301. [Abstract] [Full Text] [PDF]
	Favorable Impact of the t(9;11) in Childhood Acute Myeloid Leukemia
	Jeffrey E. Rubnitz, Susana C. Raimondi, Xin Tong, Deo Kumar Srivastava, Bassem I. Razzouk, Sheila A. Shurtleff, James R. Downing, Ching-Hon Pui, Raul C. Ribeiro, and Frederick G. Behm
	JCO May 1 2002: 2302–2309. [Abstract] [Full Text] [PDF]

Breast Cancer
	The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2
	Sunil R. Lakhani, Marc J. van de Vijver, Jocelyne Jacquemier, Thomas J. Anderson, Peter P. Osin, Lesley McGuffog, and Douglas F. Easton
	JCO May 1 2002: 2310–2318. [Abstract] [Full Text] [PDF]
	Assessment of Molecular Markers of Clinical Sensitivity to Single-Agent Taxane Therapy for Metastatic Breast Cancer
	Catherine Van Poznak, Lee Tan, Katherine S. Panageas, Crispinita D. Arroyo, Clifford Hudis, Larry Norton, and Andrew D. Seidman
	JCO May 1 2002: 2319–2326. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Treatment of Waldenström’s Macroglobulinemia With Rituximab
	Meletios A. Dimopoulos, Constantinos Zervas, Athanassios Zomas, Christos Kiamouris, Nora A. Viniou, Vassiliki Grigoraki, Christos Karkantaris, Chrisanthi Mitsouli, Dimitra Gika, John Christakis, and Nikolaos Anagnostopoulos
	JCO May 1 2002: 2327–2333. [Abstract] [Full Text] [PDF]
	Long-Term Medical Outcomes and Quality-of-Life Assessment of Patients With Chronic Myeloid Leukemia Followed at Least 10 Years After Allogeneic Bone Marrow Transplantation
	T.L. Kiss, M. Abdolell, N. Jamal, M.D. Minden, J.H. Lipton, and H.A. Messner
	JCO May 1 2002: 2334–2343. [Abstract] [Full Text] [PDF]
	Autologous Transplantation for Aggressive Non-Hodgkin’s Lymphoma: Results of a Randomized Trial Evaluating Graft Source and Minimal Residual Disease
	Julie M. Vose, Graham Sharp, Wing C. Chan, Craig Nichols, Kevin Loh, David Inwards, Robert Rifkin, Philip J. Bierman, James C. Lynch, Dennis D. Weisenburger, Anne Kessinger, and James O. Armitage
	JCO May 1 2002: 2344–2352. [Abstract] [Full Text] [PDF]
	Effects of Long-Term Intravenous Ibandronate Therapy on Skeletal-Related Events, Survival, and Bone Resorption Markers in Patients With Advanced Multiple Myeloma
	Hans D. Menssen, Adriana Sakalová, Aurélie Fontana, Zuzana Herrmann, Christian Boewer, Thierry Facon, Michail R. Lichinitser, C.R.J. Singer, Liana Euller-Ziegler, Marc Wetterwald, Denis Fiere, Mikulás Hrubisko, Eckhard Thiel, and Pierre D. Delmas
	JCO May 1 2002: 2353–2359. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Phase II Trial of the Pegylated Liposomal Doxorubicin in Previously Treated Metastatic Endometrial Cancer: A Gynecologic Oncology Group Study
	Franco M. Muggia, John A. Blessing, Joel Sorosky, and Gary C. Reid
	JCO May 1 2002: 2360–2364. [Abstract] [Full Text] [PDF]
	Phase II Trial of Weekly Single-Agent Paclitaxel in Platinum/Paclitaxel-Refractory Ovarian Cancer
	Maurie Markman, James Hall, Daniel Spitz, Sheldon Weiner, Linda Carson, Linda Van Le, and Mark Baker
	JCO May 1 2002: 2365–2369. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Temporal Change in Risk of Metachronous Contralateral Renal Cell Carcinoma: Influence of Tumor Characteristics and Demographic Factors
	Farhang Rabbani, Harry W. Herr, Taghreed Almahmeed, and Paul Russo
	JCO May 1 2002: 2370–2375. [Abstract] [Full Text] [PDF]
	Treatment Outcome and Survival Associated With Metastatic Renal Cell Carcinoma of Non–Clear-Cell Histology
	Robert J. Motzer, Jennifer Bacik, Tania Mariani, Paul Russo, Madhu Mazumdar, and Victor Reuter
	JCO May 1 2002: 2376–2381. [Abstract] [Full Text] [PDF]

Surgical Oncology
	Kyphoplasty in the Treatment of Osteolytic Vertebral Compression Fractures as a Result of Multiple Myeloma
	S. Dudeney, I.H. Lieberman, M-K. Reinhardt, and M. Hussein
	JCO May 1 2002: 2382–2387. [Abstract] [Full Text] [PDF]

BIOLOGY OF NEOPLASIA
	Clinical Relevance of MGMT in the Treatment of Cancer
	Stanton L. Gerson
	JCO May 1 2002: 2388–2399. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Unusual Presentations of Uncommon Tumors: Case 1. Benign Metastasizing Pleomorphic Adenoma

Vinay Raja, Craig China, Kamal H. Masaki, and Gordon Nakano

JCO May 1 2002: 2400–2403. [Full Text] [PDF]

Unusual Presentations of Uncommon Tumors: Case 2. Gastric Carcinoid Metastatic to the Liver

Roderich E. Schwarz, Rob A. Fuller, and Peiguo Chu

JCO May 1 2002: 2403–2404. [Full Text] [PDF]

Unusual Presentations of Uncommon Tumors: Case 3. Giant Cell Plasmacytoma Presenting as an Intraperitoneal Mass

R. V. Datta, T. Daskalakis, H. Adler, and H. Lehman

JCO May 1 2002: 2405–2406. [Full Text] [PDF]

ART OF ONCOLOGY

An Existential Oncologist

Lidia Schapira

JCO May 1 2002: 2407–2408. [Full Text] [PDF]

SPECIAL DEPARTMENTS

CORRESPONDENCE

Inhibition of Opioid Analgesia by Selective Serotonin Reuptake Inhibitors

Harry W. Daniell

JCO May 1 2002: 2409. [Full Text] [PDF]

Opioid Rotation to Methadone: Proceed With Caution

Sharon Watanabe, Yoko Tarumi, Doreen Oneschuk, Peter Lawlor, Russell K. Portenoy, and Rose Anne Indelicato

JCO May 1 2002: 2409-a–2410. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.